HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yohei Funakoshi Selected Research
Yohei Funakoshi Research Topics
Disease
17
Neoplasms (Cancer)
04/2022 - 03/2013
9
Breast Neoplasms (Breast Cancer)
03/2022 - 04/2013
4
COVID-19
04/2022 - 08/2021
4
Stomach Neoplasms (Stomach Cancer)
10/2013 - 08/2012
3
Neoplasm Metastasis (Metastasis)
04/2021 - 05/2018
2
Infections
11/2021 - 11/2021
2
Sarcoma (Soft Tissue Sarcoma)
04/2021 - 01/2021
2
Colorectal Neoplasms (Colorectal Cancer)
02/2021 - 10/2013
1
Hemorrhage
04/2022
1
Venous Thromboembolism
04/2022
1
Hematologic Diseases (Blood Diseases)
01/2022
1
Tuberculosis (Tuberculoses)
11/2021
1
Fever (Fevers)
11/2021
1
Esophageal Neoplasms (Esophageal Cancer)
11/2021
1
Ewing Sarcoma (Sarcoma, Ewing)
04/2021
1
Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
04/2021
1
Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
02/2021
1
Carcinogenesis
02/2021
1
Neutropenia
01/2021
1
Exanthema (Rash)
01/2021
1
Pancreatic Neoplasms (Pancreatic Cancer)
01/2021
1
Triple Negative Breast Neoplasms
05/2018
1
Inflammatory Breast Neoplasms
09/2017
1
Head and Neck Neoplasms (Head and Neck Cancer)
12/2016
1
Pain (Aches)
12/2016
1
Mucositis
12/2016
1
Necrosis
05/2015
1
Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
05/2015
1
Hypothyroidism
10/2013
1
Chronic Renal Insufficiency
03/2013
1
Carcinoma (Carcinomatosis)
01/2013
Drug/Important Bio-Agent (IBA)
4
Messenger RNA (mRNA)
IBA
04/2022 - 10/2015
4
Phosphotransferases (Kinase)
IBA
02/2021 - 08/2012
3
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
01/2021 - 08/2012
3
GSK 1363089
IBA
10/2013 - 08/2012
2
COVID-19 Vaccines
IBA
04/2022 - 01/2022
2
Proteins (Proteins, Gene)
FDA Link
04/2022 - 01/2018
2
BNT162 Vaccine
IBA
04/2022 - 01/2022
2
Cytokines
IBA
10/2021 - 01/2019
2
Phenobarbital (Luminal)
FDA Link
05/2018 - 07/2014
2
Trastuzumab (Herceptin)
FDA Link
01/2018 - 08/2012
2
Creatinine
IBA
02/2016 - 03/2013
2
Inulin
FDA Link
02/2016 - 03/2013
2
Tyrosine Kinase Inhibitors
IBA
10/2013 - 01/2013
2
5- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- one
IBA
10/2013 - 01/2013
1
Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
IBA
04/2022
1
apixaban
IBA
04/2022
1
Immune Checkpoint Inhibitors
IBA
04/2022
1
Anticoagulants
IBA
04/2022
1
Immunoglobulin G (IgG)
IBA
04/2022
1
Aldehyde Dehydrogenase
IBA
03/2022
1
Antibodies
IBA
11/2021
1
Nivolumab
IBA
11/2021
1
Neutralizing Antibodies
IBA
08/2021
1
Interleukin-1 Receptors (Interleukin 1 Receptor)
IBA
07/2021
1
Arginase
IBA
07/2021
1
regorafenib
IBA
02/2021
1
130-nm albumin-bound paclitaxel
IBA
01/2021
1
Gemcitabine
FDA Link
01/2021
1
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
01/2021
1
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
01/2021
1
Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
IBA
01/2021
1
Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)
IBA
01/2021
1
pazopanib
FDA Link
01/2021
1
S 1 (combination)
IBA
01/2021
1
Adipokines
IBA
01/2019
1
Complement Factor D (Factor D)
IBA
01/2019
1
Estrogen Receptors
IBA
01/2019
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
01/2019
1
Chemokines
IBA
01/2019
1
Biomarkers (Surrogate Marker)
IBA
05/2018
1
human ERBB2 protein
IBA
01/2018
1
Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)
IBA
01/2018
1
NVP-BKM120
IBA
01/2018
1
Acetaminophen (Paracetamol)
FDA Link
Generic
12/2016
1
Opioid Analgesics (Opioids)
IBA
12/2016
1
Gabapentin (Neurontin)
FDA Link
Generic
12/2016
1
Cisplatin (Platino)
FDA Link
Generic
02/2016
1
Ligands
IBA
10/2015
1
Matrix Metalloproteinase 2 (Gelatinase A)
IBA
05/2015
1
Chorionic Gonadotropin (Human Chorionic Gonadotropin)
FDA Link
Generic
05/2015
1
Tumor Biomarkers (Tumor Markers)
IBA
05/2015
1
Oxygen (Dioxygen)
IBA
04/2015
1
Pharmaceutical Preparations
IBA
04/2015
1
Caspases
IBA
04/2015
1
Bevacizumab (Avastin)
FDA Link
10/2013
1
Thyroid Hormones
IBA
10/2013
1
Insulin-Like Peptides
IBA
04/2013
1
NVP-AEW541
IBA
04/2013
1
Everolimus
FDA Link
08/2012
1
PD 173074
IBA
08/2012
1
MTOR Inhibitors
IBA
08/2012
1
Fluorouracil (Carac)
FDA Link
Generic
08/2012
Therapy/Procedure
7
Drug Therapy (Chemotherapy)
04/2022 - 03/2013
7
Therapeutics
04/2022 - 01/2009
3
Hematopoietic Stem Cell Transplantation
01/2022 - 01/2009
3
Chemoradiotherapy
11/2021 - 01/2011
2
Immunotherapy
10/2021 - 08/2021
2
Transplantation
01/2019 - 10/2015
1
Radiotherapy
01/2021